Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.
about
The ROCK pathway inhibitor Y-27632 mitigates hypoxia and oxidative stress-induced injury to retinal Müller cells.KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.Essential role of connective tissue growth factor (CTGF) in transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation from Graves' orbital fibroblasts.Repair of primary RRD - comparing pars plana vitrectomy procedure with combined phacovitrectomy with standard foldable intraocular lens implantationPathophysiology of Diabetic Retinopathy: The Old and the New
P2860
Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.
@en
Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.
@nl
type
label
Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.
@en
Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.
@nl
prefLabel
Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.
@en
Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.
@nl
P2860
P1476
Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis
@en
P2093
Frank J Lovicu
P2860
P356
10.1016/J.PRETEYERES.2017.08.001
P50
P577
2017-08-12T00:00:00Z